Skip to main content

Neuromuscular Diseases

0
Pipeline Programs
7
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Baxter International
3 programs
Oscillation and Lung ExpansionN/A
Oscillation and Lung ExpansionN/A1 trial
Oscillation and Lung Expansion therapyN/A
Active Trials
NCT05366010Terminated41Est. Feb 2024
Laurent Pharmaceuticals
1 program
ActiMyo®/Syde®N/A1 trial
Active Trials
NCT06439823Recruiting200Est. Aug 2028
ETS
ETSMO - Rolla
1 program
Intermittent Abdominal Pressure VentilationN/A1 trial
Active Trials
NCT05346263Unknown78Est. Mar 2025
Philips
PhilipsNetherlands - Amsterdam
1 program
On Demand Humidification system Mark 2N/A1 trial
Active Trials
NCT03289715Completed10Est. Jul 2018
Innovation Pharmaceuticals
1 program
Solution Focused CoachingN/A1 trial
Active Trials
NCT02997514Unknown40Est. Nov 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Laurent PharmaceuticalsActiMyo®/Syde®
ETSIntermittent Abdominal Pressure Ventilation
Baxter InternationalOscillation and Lung Expansion
PhilipsOn Demand Humidification system Mark 2
Innovation PharmaceuticalsSolution Focused Coaching

Clinical Trials (5)

Total enrollment: 369 patients across 5 trials

NCT06439823Laurent PharmaceuticalsActiMyo®/Syde®

Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function

Start: Aug 2022Est. completion: Aug 2028200 patients
N/ARecruiting
NCT05346263ETSIntermittent Abdominal Pressure Ventilation

Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients

Start: Mar 2022Est. completion: Mar 202578 patients
N/AUnknown
NCT05366010Baxter InternationalOscillation and Lung Expansion

Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients

Start: Nov 2021Est. completion: Feb 202441 patients
N/ATerminated
NCT03289715PhilipsOn Demand Humidification system Mark 2

Evaluation of an On-Demand Humidifier on Neuromuscular Patients Requiring Mechanical Ventilation

Start: Jan 2018Est. completion: Jul 201810 patients
N/ACompleted
NCT02997514Innovation PharmaceuticalsSolution Focused Coaching

Solution Focused Coaching Strategy Within a Paediatric Multidisciplinary Neuromuscular Clinic

Start: Jan 2017Est. completion: Nov 201940 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 369 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.